Top Markets
Coin of the day
Idogen AB (publ) Idogen AB (publ)

Idogen AB (publ)

IDOGEN
Rankning i aktier #37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
Aktiekurs
$0.01345907
Senast synkroniserad: 2024-07-12
Marknadsvärde
$1.43M
Förändring (1 dag)
22.16%
Förändring (1 år)
0.00%
Land
SE
Handel Idogen AB (publ) (IDOGEN)

Kategori

Historik för aktiesplit för Idogen AB (publ) (IDOGEN)
Aktien Idogen AB (publ) (symbol: IDOGEN) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 15, 2026.
En IDOGEN-aktie köpt före Aug 15, 2026 motsvarar nu 0 IDOGEN-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE